Advertisement

Topics

Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain

08:41 EDT 9 May 2019 | NEJM

Original Article: Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain

NEXT ARTICLE

More From BioPortfolio on "Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain"

Advertisement
Quick Search
Advertisement
Advertisement